Daneng Li, Associate Professor at City of Hope, shared a post on X:
“Happy to share initial findings of our IIT of Y90+STRIDE in locally advanced HCC at ESMO GI 26.
Feasible and safety consistent with known tox of agents.
Prelim ORR of 44% per RECIST consistent with prior TACE+systemic trials.
Larger studies underway․”
Other articles featuring Daneng Li on OncoDaily.